TGF-β Tumor Suppression through a Lethal EMT

Cell

Volumn 164, Issue 5, 2016, Pages 1015-1030

  David, Charles J ^a   Huang, Yun Han ^a   Chen, Mo ^b   Su, Jie ^a   Zou, Yilong ^a   Bardeesy, Nabeel ^c   Iacobuzio Donahue, Christine A ^a   Massagué, Joan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 5; SMAD4 PROTEIN; TRANSCRIPTION FACTOR SOX4; TRANSFORMING GROWTH FACTOR BETA; KLF5 PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; SMAD4 PROTEIN, MOUSE; SOX4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; EPITHELIAL MESENCHYMAL TRANSITION; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; ADENOCARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOPLASM; GENE REGULATORY NETWORK; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; PANCREAS TUMOR; PATHOLOGY;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CARCINOMA, DUCTAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE REGULATORY NETWORKS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; ORGANOIDS; PANCREATIC NEOPLASMS; SMAD4 PROTEIN; SOXC TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84959407882     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.01.009     Document Type: Article

References (63)

1. A.J. Aguirre, N. Bardeesy, M. Sinha, L. Lopez, D.A. Tuveson, J. Horner, M.S. Redston, and R.A. DePinho Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma Genes Dev. 17 2003 3112 3126
2. N. Bardeesy, K.H. Cheng, J.H. Berger, G.C. Chu, J. Pahler, P. Olson, A.F. Hezel, J. Horner, G.Y. Lauwers, D. Hanahan, and R.A. DePinho Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer Genes Dev. 20 2006 3130 3146
3. A.B. Bialkowska, Y. Liu, M.O. Nandan, and V.W. Yang A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α) J. Biol. Chem. 289 2014 5997 6005
4. S.F. Boj, C.I. Hwang, L.A. Baker, I.I. Chio, D.D. Engle, V. Corbo, M. Jager, M. Ponz-Sarvise, H. Tiriac, M.S. Spector, and et al. Organoid models of human and mouse ductal pancreatic cancer Cell 160 2015 324 338
5. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, and T. Brabletz A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep. 9 2008 582 589
6. F.G. Campos, M.N. Figueiredo, and C.A. Martinez Colorectal cancer risk in hamartomatous polyposis syndromes World J. Gastrointest. Surg. 7 2015 25 32
7. R.H. Chen, Y.H. Su, R.L. Chuang, and T.Y. Chang Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway Oncogene 17 1998 1959 1968
8. N.Y. Chia, N. Deng, K. Das, D. Huang, L. Hu, Y. Zhu, K.H. Lim, M.H. Lee, J. Wu, X.X. Sam, and et al. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development Gut 64 2015 707 719
9. C. Cicchini, D. Filippini, S. Coen, A. Marchetti, C. Cavallari, I. Laudadio, F.M. Spagnoli, T. Alonzi, and M. Tripodi Snail controls differentiation of hepatocytes by repressing HNF4alpha expression J. Cell. Physiol. 209 2006 230 238
10. S. DaCosta Byfield, C. Major, N.J. Laping, and A.B. Roberts SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7 Mol. Pharmacol. 65 2004 744 752
11. S. Doulatov, L.T. Vo, S.S. Chou, P.G. Kim, N. Arora, H. Li, B.K. Hadland, I.D. Bernstein, J.J. Collins, L.I. Zon, and G.Q. Daley Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors Cell Stem Cell 13 2013 459 470
12. D.G. Duda, M. Sunamura, L.P. Lefter, T. Furukawa, T. Yokoyama, T. Yatsuoka, T. Abe, H. Inoue, F. Motoi, S. Egawa, and et al. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells Oncogene 22 2003 6857 6864
13. ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome Nature 489 2012 57 74
14. C. Fellmann, T. Hoffmann, V. Sridhar, B. Hopfgartner, M. Muhar, M. Roth, D.Y. Lai, I.A. Barbosa, J.S. Kwon, Y. Guan, and et al. An optimized microRNA backbone for effective single-copy RNAi Cell Rep. 5 2013 1704 1713
15. H. Friess, Y. Yamanaka, M. Büchler, M. Ebert, H.G. Beger, L.I. Gold, and M. Korc Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival Gastroenterology 105 1993 1846 1856
16. T. Gaarenstroom, and C.S. Hill TGF-β signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation Semin. Cell Dev. Biol. 32 2014 107 118
17. A. Gal, T. Sjöblom, L. Fedorova, S. Imreh, H. Beug, and A. Moustakas Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis Oncogene 27 2008 1218 1230
18. L.A. Garraway, and W.R. Sellers Lineage dependency and lineage-survival oncogenes in human cancer Nat. Rev. Cancer 6 2006 593 602
19. A.M. Ghaleb, M.O. Nandan, S. Chanchevalap, W.B. Dalton, I.M. Hisamuddin, and V.W. Yang Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation Cell Res. 15 2005 92 96
20. M. Goggins, M. Shekher, K. Turnacioglu, C.J. Yeo, R.H. Hruban, and S.E. Kern Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas Cancer Res. 58 1998 5329 5332
21. G. Guasch, M. Schober, H.A. Pasolli, E.B. Conn, L. Polak, and E. Fuchs Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia Cancer Cell 12 2007 313 327
22. S.A. Hahn, M. Schutte, A.T. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, and S.E. Kern DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 1996 350 353
23. C.H. Heldin, M. Vanlandewijck, and A. Moustakas Regulation of EMT by TGFβ in cancer FEBS Lett. 586 2012 1959 1970
24. S.R. Hingorani, E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A. Jacobetz, S. Ross, T.P. Conrads, T.D. Veenstra, B.A. Hitt, and et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
25. S.R. Hingorani, L. Wang, A.S. Multani, C. Combs, T.B. Deramaudt, R.H. Hruban, A.K. Rustgi, S. Chang, and D.A. Tuveson Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice Cancer Cell 7 2005 469 483
26. K. Horiguchi, T. Shirakihara, A. Nakano, T. Imamura, K. Miyazono, and M. Saitoh Role of Ras signaling in the induction of snail by transforming growth factor-beta J. Biol. Chem. 284 2009 245 253
27. J.R. Howe, S. Roth, J.C. Ringold, R.W. Summers, H.J. Järvinen, P. Sistonen, I.P. Tomlinson, R.S. Houlston, S. Bevan, F.A. Mitros, and et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis Science 280 1998 1086 1088
28. C.A. Iacobuzio-Donahue, B. Fu, S. Yachida, M. Luo, H. Abe, C.M. Henderson, F. Vilardell, Z. Wang, J.W. Keller, P. Banerjee, and et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer J. Clin. Oncol. 27 2009 1806 1813
29. H. Ikushima, T. Todo, Y. Ino, M. Takahashi, K. Miyazawa, and K. Miyazono Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors Cell Stem Cell 5 2009 504 514
30. J.R. Kane, W.B. Laskin, K.A. Matkowskyj, C. Villa, and A.V. Yeldandi Sarcomatoid (spindle cell) carcinoma of the pancreas: A case report and review of the literature Oncol. Lett. 7 2014 245 249
31. S.K. Kim, M. Hebrok, E. Li, S.P. Oh, H. Schrewe, E.B. Harmon, J.S. Lee, and D.A. Melton Activin receptor patterning of foregut organogenesis Genes Dev. 14 2000 1866 1871
32. P.C. Konturek, A. Dembinski, Z. Warzecha, A. Ihlm, P. Ceranowicz, S.J. Konturek, J. Stachura, and E.G. Hahn Comparison of epidermal growth factor and transforming growth factor-beta1 expression in hormone-induced acute pancreatitis in rats Digestion 59 1998 110 119
33. T.I. Lee, and R.A. Young Transcriptional regulation and its misregulation in disease Cell 152 2013 1237 1251
34. A. Li, N. Omura, S.M. Hong, A. Vincent, K. Walter, M. Griffith, M. Borges, and M. Goggins Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels Cancer Res. 70 2010 5226 5237
35. E. Lonardo, P.C. Hermann, M.T. Mueller, S. Huber, A. Balic, I. Miranda-Lorenzo, S. Zagorac, S. Alcala, I. Rodriguez-Arabaolaza, J.C. Ramirez, and et al. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy Cell Stem Cell 9 2011 433 446
36. J. Massagué TGFbeta in Cancer Cell 134 2008 215 230
37. J. Massagué TGFβ signalling in context Nat. Rev. Mol. Cell Biol. 13 2012 616 630
38. J.P. Morris 4th, D.A. Cano, S. Sekine, S.C. Wang, and M. Hebrok Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice J. Clin. Invest. 120 2010 508 520
39. T. Nakaya, S. Ogawa, I. Manabe, M. Tanaka, M. Sanada, T. Sato, M.M. Taketo, K. Nakao, H. Clevers, M. Fukayama, and et al. KLF5 regulates the integrity and oncogenicity of intestinal stem cells Cancer Res. 74 2014 2882 2891
40. M.O. Nandan, A.M. Ghaleb, A.B. Bialkowska, and V.W. Yang Krüppel-like factor 5 is essential for proliferation and survival of mouse intestinal epithelial stem cells Stem Cell Res. (Amst.) 14 2015 10 19
41. S. Ohnishi, F. Laub, N. Matsumoto, M. Asaka, F. Ramirez, T. Yoshida, and M. Terada Developmental expression of the mouse gene coding for the Kruppel-like transcription factor KLF5 Dev. Dyn. 217 2000 421 429
42. N. Oshimori, and E. Fuchs The harmonies played by TGF-β in stem cell biology Cell Stem Cell 11 2012 751 764
43. N. Oshimori, D. Oristian, and E. Fuchs TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma Cell 160 2015 963 976
44. H. Peinado, M. Quintanilla, and A. Cano Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions J. Biol. Chem. 278 2003 21113 21123
45. J.D. Piñon, V. Labi, A. Egle, and A. Villunger Bim and Bmf in tissue homeostasis and malignant disease Oncogene 27 1 2008 S41 S52
46. M. Ramachandra, I. Atencio, A. Rahman, M. Vaillancourt, A. Zou, J. Avanzini, K. Wills, R. Bookstein, and P. Shabram Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis Cancer Res. 62 2002 6045 6051
47. A.D. Rhim, E.T. Mirek, N.M. Aiello, A. Maitra, J.M. Bailey, F. McAllister, M. Reichert, G.L. Beatty, A.K. Rustgi, R.H. Vonderheide, and et al. EMT and dissemination precede pancreatic tumor formation Cell 148 2012 349 361
48. M. Saborowski, A. Saborowski, J.P. Morris 4th, B. Bosbach, L.E. Dow, J. Pelletier, D.S. Klimstra, and S.W. Lowe A modular and flexible ESC-based mouse model of pancreatic cancer Genes Dev. 28 2014 85 97
49. A.A. Stepanenko, Y.S. Vassetzky, and V.M. Kavsan Antagonistic functional duality of cancer genes Gene 529 2013 199 207
50. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial-mesenchymal transitions in development and disease Cell 139 2009 871 890
51. N. Tiwari, N. Meyer-Schaller, P. Arnold, H. Antoniadis, M. Pachkov, E. van Nimwegen, and G. Christofori Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8) PLoS ONE 8 2013 e57329
52. N. Tiwari, V.K. Tiwari, L. Waldmeier, P.J. Balwierz, P. Arnold, M. Pachkov, N. Meyer-Schaller, D. Schübeler, E. van Nimwegen, and G. Christofori Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming Cancer Cell 23 2013 768 783
53. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2011 275 292
54. S.J. Vervoort, R. van Boxtel, and P.J. Coffer The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene 32 2013 3397 3409
55. T. Vincent, E.P. Neve, J.R. Johnson, A. Kukalev, F. Rojo, J. Albanell, K. Pietras, I. Virtanen, L. Philipson, P.L. Leopold, and et al. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition Nat. Cell Biol. 11 2009 943 950
56. M. Wagner, J. Kleeff, H. Friess, M.W. Büchler, and M. Korc Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer Pancreas 19 1999 370 376
57. W.A. Whyte, D.A. Orlando, D. Hnisz, B.J. Abraham, C.Y. Lin, M.H. Kagey, P.B. Rahl, T.I. Lee, and R.A. Young Master transcription factors and mediator establish super-enhancers at key cell identity genes Cell 153 2013 307 319
58. E. Wiater, and W. Vale Roles of activin family in pancreatic development and homeostasis Mol. Cell. Endocrinol. 359 2012 23 29
59. M.E. Wilson, K.Y. Yang, A. Kalousova, J. Lau, Y. Kosaka, F.C. Lynn, J. Wang, C. Mrejen, V. Episkopou, H.C. Clevers, and M.S. German The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas Diabetes 54 2005 3402 3409
60. B. Zhang, Z. Zhang, S. Xia, C. Xing, X. Ci, X. Li, R. Zhao, S. Tian, G. Ma, Z. Zhu, and et al. KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells Mol. Cell. Biol. 33 2013 4919 4935
61. H. Zhang, M. Alberich-Jorda, G. Amabile, H. Yang, P.B. Staber, A. Di Ruscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, and et al. Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia Cancer Cell 24 2013 575 588
62. X. Zheng, J.L. Carstens, J. Kim, M. Scheible, J. Kaye, H. Sugimoto, C.C. Wu, V.S. LeBleu, and R. Kalluri Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer Nature 527 2015 525 530
63. J. Zuber, J. Shi, E. Wang, A.R. Rappaport, H. Herrmann, E.A. Sison, D. Magoon, J. Qi, K. Blatt, M. Wunderlich, and et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Nature 478 2011 524 528